Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03291717 · ClinicalTrials.gov registry record · NA

Bridging Community Gaps Photovoice

A NA study of Social Isolation and Mental Illness, sponsored by Boston University Charles River Campus.

Completed
Registry status
NA
Development phase
197
Enrollment target
4
Study locations

NCT03291717: Completed NA study of Social Isolation and Mental Illness, sponsored by Boston University Charles River Campus.

NCT03291717 is a NA study of Social Isolation and Mental Illness that has completed, run by Boston University Charles River Campus. The registered enrollment target is 197 participants, roughly in line with the 196-participant average among 24 other Social Isolation trials with a reported enrollment target. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03291717, a NA study of Social Isolation and Mental Illness, has completed, sponsored by Boston University Charles River Campus.

COMPLETED
Registry status
NA
Development phase
197 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Primary Outcome

is a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.

Interventions

  • BEHAVIORAL Bridging Community Gaps Photovoice (BCGP)

Study Locations (4)

Massachusetts

  • Boston University, Center for Psychiatric Rehabilitation - Boston
  • Horizon House- Riverside Community Care - Wakefield

Colorado

  • Mental Health Center of Denver - Denver

Connecticut

  • Greater Bridgeport Mental Health Center - Bridgeport

Trial Details

FieldValue
Enrollment Target 197 participants
Start Date 2017-09-05
Est. Completion 2020-09-11
Phase NA

What the finished NCT03291717 record still lists

NCT03291717 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 196-participant average among 24 other Social Isolation trials with a reported enrollment target.

The record links to 2 conditions, with Social Isolation appearing as the primary indexed condition, and to 1 intervention - of which Bridging Community Gaps Photovoice (BCGP) is the first listed.

NCT03291717 reports a single indexed study location in Massachusetts, Colorado, Connecticut.

Frequently Asked Questions

What is clinical trial NCT03291717 about?

NCT03291717 is a clinical study titled "Bridging Community Gaps Photovoice". The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psy...

What is the current status of trial NCT03291717?

This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2017-09-05. Estimated completion is 2020-09-11.

What conditions does trial NCT03291717 study?

This clinical trial studies the following conditions: Social Isolation, Mental Illness.

What interventions are being tested in trial NCT03291717?

The interventions under investigation include: Bridging Community Gaps Photovoice (BCGP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03291717?

This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03291717 being conducted?

This trial has 4 study locations across Colorado, Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Isolation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03291717's enrollment target sits among peer trials

197 10th of 24 higher than 15 of 24 other Social Isolation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Social Isolation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04219254 · 197 participants · Phase 1

    A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

  • NCT06173778 · 197 participants · Phase 2

    Semaglutide for Post-Smoking Cessation Weight Management

  • NCT05203328 · 198 participants · NA

    Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

  • NCT05426967 · 198 participants · NA

    rTMS for Military TBI-related Depression

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03291717, the US trial registry maintained by the National Library of Medicine. NCT03291717 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.